Related Experiment Video
Updated: Jul 15, 2026
09:22
Monitoring Immune Cells Trafficking Fluorescent Prion Rods Hours after Intraperitoneal Infection
Published on: November 19, 2010
A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions.
P-C Klöhn1, L Stoltze, E Flechsig
1Medical Research Council Prion Unit, Department of Neurodegenerative Disease, Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, United Kingdom.
Summary
Researchers developed a new in vitro assay to quantify prion infectivity. This cell-based assay is faster, cheaper, and as sensitive as traditional mouse bioassays for detecting prion diseases.
Area of Science:
- Neuroscience
- Biochemistry
- Infectious Diseases
Background:
- Prion quantification typically relies on slow, costly, and imprecise mouse bioassays.
- Prion diseases are characterized by the accumulation of the scrapie form of prion protein (PrPSc).
Purpose of the Study:
- To develop a quantitative in vitro assay for prion infectivity.
- To establish a faster, more cost-effective alternative to mouse bioassays for prion detection.
Main Methods:
- Isolated neuroblastoma N2a sublines highly susceptible to mouse prions.
- Developed the scrapie cell (SC) assay using susceptible N2a cells exposed to prion samples.
- Quantified PrPSc-containing cells using automated counting after serial cell splitting.
Main Results:
- The SC assay demonstrated a linear dose-response over two logs of prion concentrations.
- The SC assay showed comparable sensitivity to mouse bioassays but was 10 times faster and over 2 orders of magnitude less expensive.
- Extended SC assays in an endpoint titration format confirmed similar infectivity titers to mouse bioassays.
Conclusions:
- The developed SC assay provides a robust, rapid, and cost-effective method for quantifying prion infectivity in vitro.
- This assay is suitable for automation and has the potential to significantly advance prion research and diagnostics.
